However, these results do not uniformly point to a direct link between insulin and cancer: despite strong preclinical evidence [208,224,225], the addition of metformin to chemotherapy for non-small cell lung cancer reduced hyperinsulinemia, but did not provide survival benefit [226]. The gene discussed is INS; the disease is Hyperinsulinemia.